1. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
    Chiara Giacomelli et al, 2021, Biochemical Pharmacology CrossRef
  2. Dual drug delivery collagen vehicles for modulation of skin fibrosis in vitro
    João Q Coentro et al, 2022, Biomed. Mater. CrossRef
    RAKESH KUMAR YADAV et al, 2022, Asian J Pharm Clin Res CrossRef
  4. Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond
    Erik P. Lillehoj et al, 2022, Front. Immunol. CrossRef
  5. Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis
    Manas Sehgal et al, 2022, Heliyon CrossRef
  6. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
    Daniela Oatis et al, 2022, IJMS CrossRef
  7. Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis
    Rui Wang et al, 2022, Front. Pharmacol. CrossRef
  8. New insights into methylome alterations and consequences during myofibroblastic differentiation in pulmonary fibrosis
    Arnaud A. Mailleux et al, 2022, Eur Respir J CrossRef
  9. BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts.
    Atsushi Suzuki et al, 2022, Am J Respir Cell Mol Biol CrossRef
  10. Evaluation of Sirtuin 1 Levels in Peripheral Blood Mononuclear Cells of Patients With Idiopathic Pulmonary Fibrosis.
    Konstantina Deskata et al, 2022, Cureus CrossRef
  11. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway
    Yang Miao et al, 2022, International Immunopharmacology CrossRef
  12. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
    Li-Li Ren et al, 2022, Chemico-Biological Interactions CrossRef
  13. TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis
    Huifang Chen et al, 2021, Cell Death Dis CrossRef
  14. The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies
    Yue-Liang Yue et al, 2022, Ther Adv Respir Dis CrossRef
  15. Plant miRNA osa-miR172d-5p suppressed lung fibrosis by targeting Tab1
    Motofumi Kumazoe et al, 2023, Sci Rep CrossRef
  16. The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis
    Xijier Qiaolongbatu et al, 2023, DDDT CrossRef
  17. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway
    Guirong Li et al, 2023, Lung CrossRef
  18. Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway
    Jing Liu et al, 2023, Journal of Ethnopharmacology CrossRef
  19. Targeting TGF-β/periostin signaling by sesamol ameliorates pulmonary fibrosis and improves lung function and survival
    Satya Krishna Tirunavalli et al, 2023, The Journal of Nutritional Biochemistry CrossRef
  20. Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
    Nikitha Naomi Dsouza et al, 2023, Inflammopharmacol CrossRef
  21. Repurposing of carvedilol to alleviate lung fibrosis in rats: Repressing of TGF-β1/α-SMA/Smad2/3 and STAT3 gene expressions
    Noha A.T. Abbas et al, 2023, Life Sciences CrossRef
  22. null
    Avanka Gunatilaka et al, 2023 CrossRef
  23. PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo
    Hu-Nan Sun et al, 2023, Cell Mol Biol Lett CrossRef
  24. Effect of FTY-720 on Pulmonary Fibrosis in Mice via the TGF-β1 Signaling Pathway and Autophagy
    Yuying Jin et al, 2023, Biomol Ther (Seoul) CrossRef
  25. Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype
    Gherardo Baudo et al, 2023, IJMS CrossRef
  26. Atractylodin Ameliorates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice
    Zhenhui Wu et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
  27. Diagnostic and therapeutic potential of transforming growth factor beta 1 in solid organ transplantation: recent research findings
    S. O. Sharapchenko et al, 2023, RJTAO CrossRef
  28. Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways
    San FU et al, 2023, Chinese Journal of Natural Medicines CrossRef
  29. Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
    Angélique Mottais et al, 2023, IJMS CrossRef
  30. Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis
    Ting Xiao et al, 2023, European Journal of Pharmacology CrossRef
  31. On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI)
    Jodi Graf et al, 2023, European Journal of Pharmaceutical Sciences CrossRef
  32. The novel peptide DR4penA attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the TGF‐β/Smad signaling pathway
    Dan Wang et al, 2023, The FASEB Journal CrossRef
  33. The main bioactive compound of Panax notoginseng, notoginsenoside R1, alleviates pulmonary fibrosis via MBD2/SHIP and STAT3 pathway
    Juan Wang et al, 2023, Journal of Functional Foods CrossRef
  34. Protein lysine acetylation played an important role in NH3-induced AEC2 damage and pulmonary fibrosis in piglets
    Xiaotong Wang et al, 2024, Science of The Total Environment CrossRef
  35. Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
    Qian Zeng et al, 2023, Sci Rep CrossRef
  36. Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
    Zhenzhen Zhang et al, 2023, BMC Pulm Med CrossRef
  37. Opposing roles for TGFβ- and BMP-signaling during nascent alveolar differentiation in the developing human lung
    Tristan Frum et al, 2023, npj Regen Med CrossRef
  38. Epithelial-fibroblast interactions in IPF: Lessons from in vitro co-culture studies
    J. Brussow et al, 2023, Differentiation CrossRef
  39. Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues
    Shobhit Gairola et al, 2023, Inflammopharmacol CrossRef
  40. Investigating rutin as a potential transforming growth factor‐β type I receptor antagonist for the inhibition of bleomycin‐induced lung fibrosis
    Wisurumuni Arachchilage Hasitha Maduranga Karunarathne et al, 2023, BioFactors CrossRef
  41. Deciphering the age-dependent changes of pulmonary fibroblasts in mice by single-cell transcriptomics
    Rundong Wu et al, 2023, Front. Cell Dev. Biol. CrossRef
  42. LncRNA SNHG8 upregulates MUC5B to induce idiopathic pulmonary fibrosis progression by targeting miR-4701-5p
    Xiaoping Zhang et al, 2023, Heliyon CrossRef
  43. The Influence of Betulin Derivatives EB5 and ECH147 on the Expression of Selected TGFβ Superfamily Genes, TGFβ1, GDF15 and BMP2, in Renal Proximal Tubule Epithelial Cells
    Sebastian Kubica et al, 2023, CIMB CrossRef
  44. Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases
    Takuma Isshiki et al, 2023, Pharmacology & Therapeutics CrossRef
  45. Club Cells—A Guardian against Occupational Hazards
    Marina Ruxandra Otelea et al, 2023, Biomedicines CrossRef
  46. Platycodin D ameliorates ammonia‐induced pulmonary fibrosis by repressing TGF‐β1‐mediated extracellular matrix remodeling
    Wenqi Lian et al, 2024, Chem Biol Drug Des CrossRef
  47. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Tom Voisin et al, 2024, The Journal of Nutritional Biochemistry CrossRef
  48. Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis
    Zeqi Wu et al, 2024, Phytomedicine CrossRef
  49. Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health
    Dulcemaría Gavito-Covarrubias et al, 2024, Front. Genet. CrossRef
  50. Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
    Wenxin Luo et al, 2023, European Journal of Medicinal Chemistry CrossRef
  51. Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers
    Aurelio Perez-Favila et al, 2024, IJMS CrossRef
  52. HSP70 Is a Critical Regulator of HSP90 Inhibitor’s Effectiveness in Preventing HCl-Induced Chronic Lung Injury and Pulmonary Fibrosis
    Ruben M. L. Colunga Biancatelli et al, 2024, IJMS CrossRef
  53. TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT)
    Archana Vijay Gaikwad et al, 2024, JCM CrossRef
  54. Summary of Experience in Using Professor Chao Enxiang’s Shenjing Wuwei Recipe to Treat Interstitial Pulmonary Fibrosis
    伟斌 吴, 2024, TCM CrossRef
  55. Qingkailing granule alleviates pulmonary fibrosis by inhibiting PI3K/AKT and SRC/STAT3 signaling pathways
    Hong Li et al, 2024, Bioorganic Chemistry CrossRef
  56. Current and Novel Treatment Modalities of Idiopathic Pulmonary Fibrosis
    Mahnoor Arshad et al, 2024 CrossRef
  57. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice
    Kaveri R. Washimkar et al, 2023, Life Sciences CrossRef
  58. Trillin Protects Against Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress and IL-1β/NLRP3 Inflammasome Positive Cycle
    Xiangyun Li et al, 2024, Natural Product Communications CrossRef
  59. İklim Değişikliğinin Vektörel Hastalıklara Etkisi ve Kırım Kongo Kanamalı Ateşi Hastalığı
    Fatih DÖKMEDEMİR et al, 2023 CrossRef
  60. Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats
    Arian Amirkhosravi et al, 2024, Sci Rep CrossRef
  61. Pulmonary fibrosis after a new coronavirus infection – versions and controversies: A review
    Evgeny I. Shchepikhin et al, 2024, Terapevticheskii arkhiv CrossRef
  62. lncRNA-mRNA Co-Expression and Regulation Analysis in Lung Fibroblasts from Idiopathic Pulmonary Fibrosis
    Armando López-Martínez et al, 2024, ncRNA CrossRef
  63. The future of chemical pleurodesis: A review of novel and investigational sclerosant agents
    Jonathan Glatt et al, 2024, The American Journal of the Medical Sciences CrossRef
  64. Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway
    Cunxiang Bo et al, 2024, BMC Pulm Med CrossRef
  65. Vinpocetine alleviated alveolar epithelial cells injury in experimental pulmonary fibrosis by targeting PPAR-γ/NLRP3/NF-κB and TGF-β1/Smad2/3 pathways
    Zeena A. Hussein et al, 2024, Sci Rep CrossRef
  66. The mysterious association between adiponectin and endometriosis
    Yong-Qing Zhao et al, 2024, Front. Pharmacol. CrossRef
  67. Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis
    Bo Ran et al, 2024, Journal of Controlled Release CrossRef
  68. Vistusertib improves pulmonary inflammation and fibrosis by modulating inflammatory/oxidative stress mediators via suppressing the mTOR signalling
    Taslim B. Shaikh et al, 2024, Inflamm. Res. CrossRef